Vaginal cabergoline in the treatment of hyperprolactinemic patients intolerant to oral dopaminergics

Fertility and Sterility

Volumn 65, Issue 2, 1996, Pages 440-442

  Motta, T ^a   De Vincentiis, S ^a   Marchini, M ^a   Colombo, N ^a   D'Alberton, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

bromocriptine; Cabergoline; macroprolactinoma; MRI

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IDIOPATHIC DISEASE; INTRAVAGINAL DRUG ADMINISTRATION; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; VERTIGO; VOMITING;

EID: 0030063569     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(16)58113-8     Document Type: Article

References (4)

1. F.G. Cuellar Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia Obstet Gynecol 55 1980 278 284
2. O.A. Kletzky M. Vermesh Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia Fertil Steril 51 1989 269 272
3. C. Ferrari A. Paracchi A.M. Mattei S. de Vincentiis A. D’Alberton P.G. Crosignani Cabergoline in the long-term therapy of hyperprolactinemic disorders Acta Endocrinol (Copenh) 126 1992 489 494
4. J. Webster G. Piscitelli A. Polli C.I. Ferrari I. Ismail M.F. Scanlon A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea N Engl J Med 331 1994 904 909